University of California, Davis

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of California, Davis sits in the top decile of US sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count).

657 total trials 123 currently recruiting 435 completed early-phase tilt top decile by trial count

University of California, Davis: 657 sponsored US clinical trials, 123 recruiting.

University of California, Davis sponsors 657 registered US clinical trials on ClinicalTrials.gov, 123 of them currently recruiting, and 435 completed. 38 of these trials are in Phase 3-4 (later-stage) and 129 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 12 trials.

Top-decile sponsor footprint

University of California, Davis ranks in the top decile of sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 65/100

435 of 483 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

657 total, page 8 of 14

TERMINATED NA

The Effects of tDCS on the Neuronal Mechanisms of Cognitive Control in Schizophrenia

NCT03077347

COMPLETED Early Phase 1

Comparison of the Cosmetic Effects of Bakuchiol and Retinol

NCT03112863

COMPLETED

Biologic Basis of Liver Cancer From Chronic Hepatitis B

NCT03300414

COMPLETED Phase 4

Gabapentin for Pain Control After Osmotic Dilator Insertion and Prior to D&E Procedure: a Randomized Controlled Trial

NCT03080493

COMPLETED NA

Singlet Oxygen Quantification After Skin Exposure to Ultraviolet A (UVA) Light

NCT05865431

TERMINATED NA

Effectiveness of Embrace Scar Therapy Device After Cutaneous Wound Closure

NCT03294863

COMPLETED Phase 4

TAP Block Catheters vs Liposomal Bupivacaine for Pain Control After Colorectal Surgery

NCT03080142

COMPLETED NA

Food Matrix Effect on Flavanol Absorption, Metabolism and Excretion: Methylxanthines

NCT03526107

COMPLETED

Using Breath Metabolites to Determine Specific Virus Infection in Asthmatic Patients

NCT03089970

COMPLETED NA

School-Based Tele-Physiatry Assistance for Rehabilitative and Therapeutic Services

NCT03320122

COMPLETED NA

Acceptability and Tolerance of a Protein and Micronutrient Fortified Food

NCT03041103

COMPLETED Phase 1

Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer

NCT03123978

COMPLETED NA

A Multidimensional Behavioral Intervention for Those at Risk for Alzheimer's Dementia

NCT03549078

COMPLETED Early Phase 1

Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis

NCT03114111

COMPLETED NA

A Multifaceted Intervention to Improve Prescribing for Acute Respiratory Infection for Adults and Children in Emergency Department and Urgent Care Settings

NCT03022929

TERMINATED NA

Feasibility of a Non-invasive, Trans-abdominal, Low Cost Fetal Oximetry Probe on Pregnant Human Subjects

NCT03013842

COMPLETED NA

Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department

NCT02957136

COMPLETED NA

Men and Providers Preventing Suicide (MAPS)

NCT02986113

COMPLETED NA

Turmeric and Curcumin on Sebum Production

NCT03066791

COMPLETED Phase 1

Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer

NCT02899078

COMPLETED NA

Turmeric and Turmeric-containing Tablets and Sebum Production

NCT03065504

COMPLETED NA

The Effect of Almonds on Skin Lipids and Wrinkles

NCT02954315

TERMINATED Phase 4

Post-Operative Therapy for Nausea or Vomiting

NCT03075163

COMPLETED NA

The Effect of Daily Mango Intake on Cardiovascular Health

NCT03203187

COMPLETED NA

Motivating Our Mothers 2

NCT02938598

COMPLETED Phase 1

Nitrosomonas Eutropha on Nitrolipids in the Skin

NCT02938650

COMPLETED NA

Pilot Study of the Pragmatic Use of Mobile Phone Based Follow up of Actinic Keratoses Treated With Topical 5-fluorouracil

NCT02938715

COMPLETED Phase 4

Nexplanon and Combined Oral Contraceptive (COC) Combined Use Study

NCT02852265

TERMINATED NA

Comparison of Preoperative Ultrasound Guided Pectoralis Nerve Block Placement Versus Intra-operative Placement: A Prospective Randomized Trial

NCT03201809

COMPLETED NA

Dried Cabernet Grapes and Cardiovascular Risk Markers

NCT03065166

COMPLETED NA

Absorption, Metabolism and Excretion of Dietary Polyphenolic Bioactives in Humans

NCT03194620

COMPLETED NA

CPAP to Improve Swallow Function Post Total Laryngectomy

NCT03328702

COMPLETED Phase 1

Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer

NCT02339168

COMPLETED NA

Flavanol Absorption, Metabolism and Excretion From Fruit-based Drinks and Other Food Matrixes

NCT03526094

COMPLETED NA

Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris

NCT02905851

COMPLETED NA

Use of a Non-ICU Specialty Ward For Immediate Post-operative Management of Head and Neck Free Flaps

NCT03340038

COMPLETED NA

Effects of Short-term Diet on HDL Composition and Function

NCT03205254

TERMINATED Phase 4

Flumazenil for Hypoactive Delirium Secondary to Benzodiazepine Exposure

NCT02899156

COMPLETED NA

Adverse Metabolic Effects of Dietary Sugar

NCT02548767

COMPLETED NA

Improving Health in Diabetes Project

NCT02672176

TERMINATED Phase 4

Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department

NCT02930941

COMPLETED NA

Comparison of Colon Adenoma Detection Rate Using Two Distal Colonoscope Attachments

NCT02665741

COMPLETED Phase 4

Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome

NCT02642653

COMPLETED NA

Topical Acetyl Hexapeptide-8 and the Cosmetic Appearance of Oily Skin

NCT02597777

COMPLETED NA

The Effects of Yoga on Attention, Impulsivity and Hyperactivity in Pre-school Age Children

NCT02642666

TERMINATED NA

Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial

NCT03010137

COMPLETED NA

A Family-based Primary Care Intervention to Enhance Older Men's Depression Care

NCT02143024

COMPLETED

Evaluation of Objective Outcomes With the Use of an Activity Tracker During the Trial Period of Spinal Cord Stimulation

NCT02641223

COMPLETED NA

Evidence-Based Tele-Emergency Network Grant Program

NCT02877810

COMPLETED NA

Wound Eversion Versus Planar Closure for Face or Neck Wounds

NCT03302988

← Previous Page 8 of 14 Next →

Phase Distribution

PhaseTrial count
Phase 1 86
Phase 2 43
Phase 3 10
Phase 4 28

What is open in the University of California, Davis pipeline

123 recruiting of 657 indexed (19% open); 435 completed (66%).

Phase mix: 38 late (III/IV) vs 129 early (I/II) (early-phase heavy).

Top condition: Healthy (12 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of California, Davis: open-pipeline peers nationwide

Peers matched on 657 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

University of California, Davis sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600800 0%5%10%15%20%25% Total trials Recruiting share University of California, DavisVanderbilt University Medical CenterUniversity of RochesterUS Department of Veterans AffairsThe Cleveland ClinicEyePoint PharmaceuticalsHebrew SeniorLifeInsulet CorporationMedical University of South Carolina
University of California, Davis sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of California, Davis sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 657 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this University of California, Davis page

657 registered trials is a research-attention snapshot, not an endorsement of University of California, Davis or any single study.

  • 123 of University of California, Davis's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Healthy is the condition University of California, Davis studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Davis pipeline card: 657 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.